Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

HK Type 4 license through Ballingal Investment Advisors Ltd. ("BIA" or "BIAL")

BACKGROUND
I have 20+yrs experience in Asia doing alternative strategies (i.e. non-delta1 non long-only) in fixed income, equity derivatives, and activist/catalyst/event-driven and long-short equity strategies with most of that time spent managing money. 

4 years in fixed income macro, 8 years running internal hedge fund and 4yrs investment banking at Citi in Japan, 3 years running an Asia multi-strat portfolio at a hedge fund, 4+yrs as an independent special situations analyst.

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>Large Japanese low-multiple pharma company <a href="https://www.smartkarma.com/entities/astellas-pharma-inc" target="_blank" data-smartkarma-citation="entities:6091:1" rel="noopener">Astellas Pharma (4503 JP)</a> yesterday announced earnings and this morning announced a buyback. </li>
<li>The buyback is small-ish, but the details are definitely worth knowing. </li>
<li>A play against peers for the period and afterwards may have some merit. If you have an execution axe, definitely worth a look.</li>
</ul>


Large Japanese low-multiple pharma company Astellas Pharma (4503 JP) yesterday announced earnings and this morning announced a buyback. 
The buyback is small-ish, but the details are definitely worth knowing. 
A play against peers for the period and afterwards may have some merit. If you have an execution axe, definitely worth a look.


Astellas Pharma (4503) Buyback - Short-Term Pressure Catalyst